Press Releases for GPC

Press Releases
RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on GPC, PVH, TMR, FRO, VOD and TLB
Genuine Parts Company Declares Regular Quarterly Dividend and Announces Officer Change
Genuine Parts Company Reports Sales and Earnings for the Second Quarter and Six Months Ended June 30, 2009
Genuine Parts Company Announces New President U.S. Automotive Parts Group
StreetInvesting.Com Free Research on CYT, R, VLY, BPZ, GPC and MLM
Genuine Parts Company Announces Second Quarter 2009 Earnings Release Date and Conference Call
New Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor Presented at AACR
Genuine Parts Company Declares Regular Quarterly Dividend
Genuine Parts Company Reports First Quarter 2009 Results
AnalystChoice.Com Free Investment Opinion on ARM, GIL, GPC and HBI
Genuine Parts Company Announces 1st Quarter 2009 Earnings Release Date and Conference Call
GPC Biotech to Hold Meeting and Conference Call on March 25, 2009 to Discuss Year-End 2008 Financial Results
GPC Biotech AG Announces Dismissal of U.S. Class Action Lawsuit
Safety and Overall Survival Data in Docetaxel-Refractory Patients Enrolled in the Satraplatin SPARC Trial Being Presented at 2009 ASCO Genitourinary Cancers Symposium
GPC Biotech and Agennix Announce Proposed Merger
Genuine Parts Company Reports Results for 2008 Sales Increased 2%, EPS Decreased 2%
Zacks Sell List Highlights: NYSE Euronext, Regal Beloit Corp., Genuine Parts Co. And V.F. Corp.
Genuine Parts Company Announces 4th Quarter and 2008 Earnings Release Date and Conference Call
Genuine Parts Company Updates 2008 Sales and Earnings Expectations
BenchmarkJournal.Com (Complimentary) Analyst Review for MET, CLF, LSI and GPC
GPC Biotech Opens Enrollment in Phase 1 Trial Evaluating RGB-286638 Multi-Targeted Protein Kinase Inhibitor in Patients with Advanced Solid Tumors
GPC Biotech Announces Presentation of New Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor at the American Society of Hematology Annual Meeting
Genuine Parts Company Declares Regular Quarterly Dividend and Announces Additional 15 Million Share Repurchase Program
GPC Biotech Reports Financial Results For Third Quarter and First Nine Months of 2008
GPC Biotech Schedules Conference Call on November 13th to Discuss Third Quarter 2008 Financial Results
GPC Biotech to Present at Rodman & Renshaw Annual Global Investment Conference in New York
GPC Biotech Presents New Pre-Clinical Data on RGB-286638 Broad-Spectrum Kinase Inhibitor at EORTC-NCI-AACR Meeting
Analyst Reports for Eaton Corporation, The Stanley Works, Genuine Parts Company and Schlumberger Limited
Genuine Parts Company Reports Increased Sales and Earnings for Third Quarter and Nine Months Ended September 30, 2008
Gabelli & Company's 32nd Annual Automotive Aftermarket Symposium
Genuine Parts Company Announces 3rd Quarter 2008 Earnings Release Date and Conference Call
Genuine Parts Company Announces Acquisition of Drago Supply Company
Genuine Parts Company Declares Regular Quarterly Dividend and Announces Agreement to Purchase the Midwestern U.S. Business of ActionEmco
GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2008
GPC Biotech Schedules Conference Call on August 13th to Discuss First Half 2008 Financial Results
GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin
GPC Biotech Reports That Marketing Authorization Application for Satraplatin is to Be Withdrawn
Genuine Parts Company Reports Record Sales and Earnings for the Second Quarter and Six Months Ending June 30, 2008
GPC Biotech To Re-Schedule Annual Shareholders' Meeting
Genuine Parts Company Announces 2nd Quarter 2008 Earnings Release Date and Conference Call
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hormone-Refractory Prostate Cancer Previously Treated with Docetaxel
GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to Taxanes
BeaconEquity.com Issues TraderNotes on Auto Part Stocks: GNAU, LKQX, GPC, SMP, MOD, LEA, ALV, TKS
GPC Biotech to Present at Two Upcoming Conferences: 7th Annual Needham Biotechnology & Medical Technology Conference in New York and Piper Jaffray Europe Conference in London
Data from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial Chemotherapy Presented at 44th ASCO Annual Meeting
New Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual Meeting
BeaconEquity.com Issues TraderNotes on Aftermarket Auto Parts Stocks: GNAU, MWWC, GPC, CRV, LKQX, MPAA, QTWW, GNTX
GPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual Meeting
GPC Biotech Reports Financial Results for First Quarter 2008 - Jun 3 2008 3:16AM
GPC Biotech Schedules Conference Call on May 15th to Discuss First Quarter 2008 Financial Results - Jun 3 2008 3:15AM
Genuine Parts Company Declares Regular Quarterly Dividend
Genuine Parts Company Reports First Quarter 2008 Results Sales Increased 3%, EPS Increased 6%
Motion Industries Earns a Premier Supplier Award from Eaton
Genuine Parts Company Announces 1st Quarter 2008 Earnings Release Date and Conference Call
GPC Biotech to Present at Second Annual Piper Jaffray London Health Care Conference